Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cytosorbents ( (CTSO) ) just unveiled an announcement.
CytoSorbents Corporation announced a rights offering, providing eligible stockholders and warrantholders the chance to purchase units consisting of common stock and warrants at a set price. This financial move could intrigue investors looking to expand their holdings, especially with the oversubscription privilege allowing for additional unit purchases. However, investors should act promptly as the rights and potential ownership stakes will expire without value if not exercised by January 10, 2025.
For an in-depth examination of CTSO stock, go to TipRanks’ Stock Analysis page.

